Analyst
Goldman Sachs
Equibles does not estimate personal net worth.
Karan Boda is recorded as Analyst at Goldman Sachs. Karan Boda has spoken on 1 earnings call across 1 company, most recently for Gland Pharma Limited on November 6, 2026. The companies whose calls Karan Boda spoke on are classified in the Healthcare sector.
“My first question is with respect to the U.S. business. So can you highlight what is the U.S. business growth excluding Cenex C also in the current quarter as well as in the base?”
Goldman Sachs
Analyst
Transcript header (unverified)
Gland Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Gland Pharma Limited
